The drug development landscape in Parkinson's

This event will be held in person. Please note slightly the later start time of 12:15pm

Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (bit.ly/ParkinsonsHopeList), a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.

Date: 24 May 2022, 12:15 (Tuesday, 5th week, Trinity 2022)
Venue:
Dorothy Crowfoot Hodgkin Building
off South Parks Road OX1 3QU
See location on maps.ox

Details: This seminar will be held in the Dorothy Crowfoot Hodgkin Building (Phase II Biochemistry), Ground Floor Seminar Room (20-140). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker: Dr Kevin McFarthing (Research Advisor, Parkinson’s UK Oxford Branch)
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Lorraine Dyson (University of Oxford)
Organiser contact email address: opdc.administrator@dpag.ox.ac.uk
Host: Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of: OPDC Seminar Series (DPAG)
Booking required?: Not required
Audience: Members of the University only
Editors: Samuel Press, Lorraine Dyson